SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-20-006795
Filing Date
2020-04-21
Accepted
2020-04-20 19:21:19
Documents
10
Period of Report
2020-04-20

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 17193
2 ex99-1.htm EX-99.1 1166128
3 ex99-2.htm EX-99.2 3740
4 ex99-1_001.jpg GRAPHIC 8663
5 ex99-1_002.jpg GRAPHIC 8663
6 ex99-1_003.jpg GRAPHIC 28017
7 ex99-2_001.jpg GRAPHIC 118879
8 ex99-2_002.jpg GRAPHIC 23028
9 ex99-2_003.jpg GRAPHIC 102081
10 ex99-2_004.jpg GRAPHIC 29724
  Complete submission text file 0001493152-20-006795.txt   1628348
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 20803678
SIC: 2834 Pharmaceutical Preparations